JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 40 filers reported holding JUNIPER PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,808,000 | +1.4% | 501,502 | +0.5% | 0.00% | – |
| Q3 2016 | $2,768,000 | -21.8% | 498,821 | -1.2% | 0.00% | -100.0% |
| Q2 2016 | $3,538,000 | -2.0% | 504,702 | -7.6% | 0.00% | 0.0% |
| Q1 2016 | $3,610,000 | -24.5% | 546,189 | +17.7% | 0.00% | 0.0% |
| Q4 2015 | $4,781,000 | -10.5% | 464,137 | +2.3% | 0.00% | 0.0% |
| Q3 2015 | $5,343,000 | +54.4% | 453,531 | +19.9% | 0.00% | 0.0% |
| Q2 2015 | $3,460,000 | – | 378,192 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 481,459 | $5,672,000 | 2.05% |
| Krensavage Asset Management, LLC | 279,717 | $3,295,000 | 1.19% |
| EAM Investors, LLC | 145,898 | $1,719,000 | 0.27% |
| PERRITT CAPITAL MANAGEMENT INC | 93,000 | $1,096,000 | 0.23% |
| TFS CAPITAL LLC | 99,823 | $1,176,000 | 0.11% |
| Bellevue Asset Management AG | 50,000 | $589,000 | 0.10% |
| CADENCE CAPITAL MANAGEMENT LLC | 88,232 | $1,039,000 | 0.07% |
| Spark Investment Management LLC | 39,200 | $461,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 100,564 | $1,185,000 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 35,599 | $419,000 | 0.03% |